CTRE vs NHI

Key Takeaways

• CareTrust REIT (CTRE) and National Health Investors (NHI) are both healthcare-focused REITs (Real Estate Investment Trusts), but they differ substantially in scale, growth trajectory, and portfolio composition.
• CTRE has delivered a standout one-year total return exceeding 43%, driven by record investment deployment of $1.8 billion in 2025, while NHI has posted a more modest but still robust one-year return of approximately 18.6%.
• NHI offers a notably higher dividend yield of roughly 4.6% compared to CTRE's approximately 3.6%, which may appeal to income-oriented investors.
• CTRE operates with exceptionally low leverage (net debt-to-EBITDA of 0.7x) versus NHI's leverage below 4.0x, giving CTRE significantly more balance-sheet flexibility for future acquisitions.
• NHI is expanding its SHOP (Senior Housing Operating Portfolio) segment aggressively, while CTRE has diversified internationally through its entry into the UK care home market.
• Both companies ended 2025 with strong momentum, but CTRE's growth rate, pipeline scale, and capital position currently stand out in a direct comparison.

Introduction

Healthcare real estate investment trusts occupy a distinctive niche at the intersection of property markets and the powerful demographic tailwind of an aging population. For investors seeking exposure to this space, CTRE (CareTrust REIT) and NHI (National Health Investors) represent two compelling but meaningfully different approaches. Both companies own and finance skilled nursing facilities, senior housing communities, and other healthcare properties, yet their strategies around growth, leverage, international diversification, and operating models create a rich contrast. This stock comparison examines how these two healthcare REITs have performed amid a dynamic market environment and what distinguishes their positioning heading into the second half of 2026.

CTRE Overview and Recent Performance

CareTrust REIT, headquartered in Dana Point, California, has emerged as one of the fastest-growing healthcare REITs in the market. The company owns a diversified portfolio of 579 properties spread across 33 U.S. states and the United Kingdom, encompassing skilled nursing facilities, senior housing, UK care homes, and other healthcare-related assets. CTRE leases its properties to healthcare operators under triple-net lease arrangements, which transfer most operating costs to tenants.

In recent market activity, CTRE shares have demonstrated considerable strength, trading near the upper end of their 52-week range. The stock has posted a year-to-date gain of approximately 22% as of late July 2026 and a one-year total return exceeding 43%. This performance has been propelled by a record year in 2025, during which the company deployed approximately $1.8 billion in investment activity at a blended stabilized yield of 8.6%. Full-year 2025 normalized FFO (Funds From Operations, a key REIT earnings metric) reached $1.76 per share, representing 17% growth over the prior year.

Two strategic moves have meaningfully reshaped CTRE's growth profile: the acquisition of Care REIT plc, which provided entry into the UK care home market, and the expansion of its SHOP (Senior Housing Operating Portfolio) segment. The company's balance sheet remains a standout feature, with net debt-to-annualized normalized run rate EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of just 0.7x at year-end 2025 — far below its target leverage range of 4.0x to 5.0x — and full availability on its $1.2 billion revolving credit facility. For 2026, management has guided to normalized FFO of $1.90 to $1.95 per share, implying roughly 9.4% growth at the midpoint.

NHI Overview and Recent Performance

National Health Investors, based in Murfreesboro, Tennessee, is a self-managed REIT with a decades-long track record specializing in senior housing and medical facility investments. NHI's portfolio spans independent living facilities, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals. The company operates through two segments: Real Estate Investments (comprising leases, mortgages, and notes receivable) and its growing SHOP segment.

NHI shares have delivered a solid but comparatively more measured performance in recent months. The stock has risen approximately 7.9% year-to-date as of late July 2026 and roughly 18.6% over the trailing one-year period. In 2025, NHI announced investments totaling $392.3 million — its most active year since 2016 — and expanded its SHOP portfolio from 15 to 26 properties, with a further nine-property acquisition for $105.5 million announced subsequently, bringing total SHOP investments to approximately $740 million.

Full-year 2025 normalized FFO reached $4.91 per diluted share, exceeding the midpoint of the company's initial guidance by nearly 6%. SHOP net operating income (NOI) grew approximately 63% year-over-year in the third quarter of 2025, reflecting the successful property transitions. NHI's balance sheet carries net debt-to-adjusted EBITDA below 4.0x, and the company has guided for 2026 normalized FFO in the range of $4.94 to $4.99 per share. The stock currently offers a forward dividend yield of roughly 4.6%, and its beta of 0.54 indicates lower volatility than the broader market.

Trending AI Robots

For investors seeking a data-driven edge in evaluating stocks like CTRE and NHI, Tickeron's Trending AI Robots page offers a curated selection of AI-powered trading bots designed to navigate real-time market conditions. Tickeron hosts hundreds of AI trading bots that collectively trade thousands of different tickers across multiple strategies, timeframes, and asset classes. However, only a select subset earns placement in the Trending AI Robots section — those demonstrating the strongest alignment with current market dynamics. These bots employ a range of approaches, from swing trading and trend following to pattern recognition and momentum-based strategies, with varied historical performance statistics that include win rates, annualized returns, and drawdown metrics. Each bot maintains its own distinct portfolio of tickers and risk parameters, allowing users to explore AI-driven trade signals tailored to different investing styles. Discover which strategies are currently resonating with the market by visiting the Trending AI Robots page.

Head-to-Head Comparison

When placed side by side, the contrasts between CTRE and NHI are sharp and instructive. Scale and market capitalization represent the most immediate difference: CTRE commands a market cap of approximately $10.2 billion, nearly three times NHI's roughly $3.9 billion, reflecting the former's more aggressive external growth strategy and larger equity base following a $736 million public offering in the third quarter of 2025.

On growth momentum, CTRE has been the clear leader in recent quarters. Its $1.8 billion in 2025 investment activity dramatically outpaced NHI's $392.3 million, and CTRE's normalized FFO per share growth of 17% exceeded NHI's approximately 10.6% normalized FFO per share growth over the same period. CTRE's expansion into the UK and its rapidly replenishing pipeline of $500 million suggest the growth differential may persist.

Regarding income and valuation, NHI holds the advantage for yield-focused investors, offering a forward dividend yield of about 4.6% versus CTRE's 3.6%. NHI also trades at a slightly lower P/E (Price-to-Earnings) ratio of approximately 26.0 compared to CTRE's 27.4. However, CTRE's lower dividend payout ratio (roughly 73% of normalized FAD, or Funds Available for Distribution) compared to NHI's indicates greater capacity for dividend growth or reinvestment.

On balance sheet strength, CTRE's position is notably more conservative. A net debt-to-EBITDA ratio of 0.7x, zero borrowings on a $1.2 billion revolver, and no debt maturities before 2028 provide CTRE with abundant dry powder. NHI's leverage below 4.0x is reasonable by REIT industry standards but leaves less room for opportunistic acquisitions without additional equity or debt issuance.

Risk profiles diverge as well. CTRE's tenant concentration — with its largest tenant, The Ensign Group, accounting for roughly 25% of rental income — introduces single-operator risk that NHI's more diversified tenant base partially mitigates. NHI's lower beta of 0.54 versus CTRE's 0.79 also suggests historically lower price volatility. Conversely, CTRE's 100% contractual rent collection rate and expanding geographic footprint across two countries provide a different form of resilience.

Tickeron AI Verdict

Based on observable factors including trend consistency, growth momentum, balance sheet capacity, and relative market positioning, Tickeron's AI-driven analysis would likely express a preference for CTRE in the current environment. The combination of a 43%-plus one-year total return, record-setting investment deployment, exceptionally low leverage, and a clearly articulated growth runway across both the U.S. and UK markets suggests a more powerful and sustained upward trajectory. CTRE's normalized FFO growth guidance of approximately 9.4% for 2026, supported by a $500 million pipeline, indicates that the company's momentum has not yet fully played out. That said, NHI remains a structurally sound and well-managed REIT with a higher current yield and a compelling SHOP expansion narrative. For AI models that prioritize trend strength, capital flexibility, and growth scalability, however, CTRE currently presents the more favorable configuration of risk-adjusted return potential.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations